Idarucizumab: a novel antidote for reversal of dabigatran.

Abdul Rehman Alvi, Muhammad Muhammad Awais, Noor Ul-Ain Baloch

Research output: Contribution to journalArticle

Original languageUndefined/Unknown
JournalDepartment of Surgery
Publication statusPublished - 1 Mar 2016

Cite this